| Therapeutic vaccines for high-risk HPV-associated diseases A Chabeda, RJR Yanez, R Lamprecht, AE Meyers, EP Rybicki, II Hitzeroth Papillomavirus research 5, 46-58, 2018 | 221 | 2018 |
| A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus‐like particles EC Thuenemann, AE Meyers, J Verwey, EP Rybicki, GP Lomonossoff Plant biotechnology journal 11 (7), 839-846, 2013 | 157 | 2013 |
| Expression of HIV-1 antigens in plants as potential subunit vaccines A Meyers, E Chakauya, E Shephard, FL Tanzer, J Maclean, A Lynch, ... BMC biotechnology 8, 1-15, 2008 | 135 | 2008 |
| The use of transient expression systems for the rapid production of virus-like particles in plants E C Thuenemann, P Lenzi, A J Love, M Taliansky, M Bécares, S Zuñiga, ... Current pharmaceutical design 19 (31), 5564-5573, 2013 | 84 | 2013 |
| Production of complex viral glycoproteins in plants as vaccine immunogens E Margolin, R Chapman, AL Williamson, EP Rybicki, AE Meyers Plant biotechnology journal 16 (9), 1531-1545, 2018 | 79 | 2018 |
| African horse sickness: A review of current understanding and vaccine development SJ Dennis, AE Meyers, II Hitzeroth, EP Rybicki Viruses 11 (9), 844, 2019 | 66 | 2019 |
| Co‐expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants E Margolin, YJ Oh, M Verbeek, J Naude, D Ponndorf, YA Meshcheriakova, ... Plant Biotechnology Journal 18 (10), 2109-2117, 2020 | 56 | 2020 |
| Optimization of chimeric HIV‐1 virus‐like particle production in a baculovirus‐insect cell expression system S Pillay, A Meyers, AL Williamson, EP Rybicki Biotechnology progress 25 (4), 1153-1160, 2009 | 53 | 2009 |
| Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice M Whitehead, P Öhlschläger, FN Almajhdi, L Alloza, P Marzábal, ... BMC cancer 14, 1-15, 2014 | 52 | 2014 |
| Engineering the plant secretory pathway for the production of next-generation pharmaceuticals EA Margolin, R Strasser, R Chapman, AL Williamson, EP Rybicki, ... Trends in biotechnology 38 (9), 1034-1044, 2020 | 46 | 2020 |
| A prime–boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in … GK Chege, R Thomas, EG Shephard, A Meyers, W Bourn, C Williamson, ... Vaccine 27 (35), 4857-4866, 2009 | 44 | 2009 |
| Stability studies of HIV-1 Pr55gagvirus-like particles made in insect cells after storage in various formulation media A Lynch, AE Meyers, AL Williamson, EP Rybicki Virology journal 9, 1-5, 2012 | 42 | 2012 |
| Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice A Jaffray, E Shephard, J van Harmelen, C Williamson, AL Williamson, ... Journal of general virology 85 (2), 409-413, 2004 | 41 | 2004 |
| Production and immunogenicity of soluble plant-produced HIV-1 subtype C envelope gp140 immunogens E Margolin, R Chapman, AE Meyers, MT Van Diepen, P Ximba, ... Frontiers in plant science 10, 1378, 2019 | 40 | 2019 |
| HIV-1 subtype C Pr55gag virus-like particle vaccine efficiently boosts baboons primed with a matched DNA vaccine GK Chege, EG Shephard, A Meyers, J van Harmelen, C Williamson, ... Journal of general virology 89 (9), 2214-2227, 2008 | 37 | 2008 |
| Immunogenicity of plant‐produced African horse sickness virus‐like particles: implications for a novel vaccine SJ Dennis, AE Meyers, AJ Guthrie, II Hitzeroth, EP Rybicki Plant biotechnology journal 16 (2), 442-450, 2018 | 35 | 2018 |
| Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses SJ Dennis, MM O’kennedy, D Rutkowska, T Tsekoa, CW Lourens, ... Veterinary research 49 (1), 1-6, 2018 | 34 | 2018 |
| Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana VP Veerapen, AR Van Zyl, A Wigdorovitz, EP Rybicki, AE Meyers Virus research 244, 213-217, 2018 | 33 | 2018 |
| Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model GK Chege, WA Burgers, H Stutz, AE Meyers, R Chapman, A Kiravu, ... Journal of virology 87 (9), 5151-5160, 2013 | 31 | 2013 |
| Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles RJ Halsey, FL Tanzer, A Meyers, S Pillay, A Lynch, E Shephard, ... Virus research 133 (2), 259-268, 2008 | 31 | 2008 |
